Table 5.
Treatment Comparison | Gene | Description | Fold change | P-value |
---|---|---|---|---|
ALa+LPSb vs AL + CONc | AIG1 | Androgen-induced 1 | −1.82 | 0.019 |
HSDL2 | Hydroxysteroid Dehydrogenase like 2 | −1.77 | 0.011 | |
HSD11B1 | 11β Hydroxysteroid dehydrogenase type 1 | −1.67 | 0.030 | |
AVPR1 | Arginine vasopressin receptor 1 | −1.62 | 0.015 | |
HSDL1 | Hydroxysteroid Dehydrogenase like 1 | 1.24 | 0.039 | |
FOd+LPS vs FO + CON | MRAP2 | Melanocortin 2 receptor accessory protein 2 | −1.58 | 0.025 |
CYP39A1 | Cytochrome P450 39A1 | −1.44 | 0.017 | |
CYP1a2 | Cytochrome P450 1A2 | 1.21 | 0.039 | |
CYP4F2 | Cytochrome P450 4F2 | 1.42 | 0.040 | |
CRHBP | Corticotropic releasing hormone binding protein | 1.44 | 0.047 | |
AL + LPS vs COe+LPS | CYP2J2L | Cytochrome P450 2J2 like | 1.52 | 0.035 |
AL + CON vs CO + CON | ADRA2A | Adrenoreceptor alpha 2A | −1.27 | 0.025 |
ADRBK2 | β-Adrenergic receptor kinase 2 | 1.40 | 0.008 | |
GLCCI1 | Glucocorticoid induced 1 | 1.45 | 0.003 | |
FO + LPS vs CO + LPS | CYP2J2L | Cytochrome P450 2J2 like | 1.42 | 0.022 |
FO + CON vs CO + CON | ADRBK2 | β-Adrenergic receptor kinase 2 | 1.21 | 0.023 |
HSD11B2 | 11β Hydroxysteroid dehydrogenase type 2 | 1.71 | 0.023 | |
AL + LPS vs FO + LPS | HSD11B2 | 11β Hydroxysteroid dehydrogenase type 2 | −1.57 | 0.019 |
HSDL2 | Hydroxysteroid dehydrogenase like 2 | −1.49 | 0.038 | |
HSDL1 | Hydroxysteroid dehydrogenase like 1 | 1.22 | 0.041 | |
CYP1A1 | Cytochrome P450 1A1 | 1.31 | 0.020 | |
AL + CON vs FO + CON | HSD17B8 | 17β Hydroxysteroid Dehydrogenase type 8 | −1.31 | 0.033 |
AL, microalgae.
LPS, lipopolysaccharide.
CON, saline control.
FO, fish oil.
CO, corn oil.